Kodiak Sciences Shares Outstanding History (KOD)
Kodiak Sciences reported 61.8M shares outstanding at the end of fiscal 2025.
View full Kodiak Sciences company overviewKodiak Sciences annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 61.8M | 9.0M | +17.13% |
| 2024 | 2024-12-31 | 52.7M | 218,314 | +0.42% |
| 2023 | 2023-12-31 | 52.5M | 174,752 | +0.33% |
| 2022 | 2022-12-31 | 52.3M | 507,593 | +0.98% |
| 2021 | 2021-12-31 | 51.8M | 713,955 | +1.40% |
| 2020 | 2020-12-31 | 51.1M | 6.7M | +15.08% |
| 2019 | 2019-12-31 | 44.4M | 7.6M | +20.59% |
| 2018 | 2018-12-31 | 36.8M | 28.9M | +364.06% |
| 2017 | 2017-12-31 | 7.9M | — | — |
Kodiak Sciences quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 62.8M | 10.0M | +18.95% |
| Q1 2026 | 2026-03-31 | 62.2M | 9.4M | +17.83% |
| Q4 2025 | 2025-12-31 | 61.8M | 9.0M | +17.13% |
| Q3 2025 | 2025-09-30 | 53.0M | 375,474 | +0.71% |
| Q2 2025 | 2025-06-30 | 52.8M | 206,960 | +0.39% |
| Q1 2025 | 2025-03-31 | 52.8M | 228,428 | +0.43% |
| Q4 2024 | 2024-12-31 | 52.7M | 218,314 | +0.42% |
| Q3 2024 | 2024-09-30 | 52.6M | 155,796 | +0.30% |
| Q2 2024 | 2024-06-30 | 52.6M | 161,566 | +0.31% |
| Q1 2024 | 2024-03-31 | 52.5M | 178,706 | +0.34% |
| Q4 2023 | 2023-12-31 | 52.5M | 174,752 | +0.33% |
| Q3 2023 | 2023-09-30 | 52.5M | 163,137 | +0.31% |
| Q2 2023 | 2023-06-30 | 52.5M | 428,542 | +0.82% |
| Q1 2023 | 2023-03-31 | 52.3M | 404,860 | +0.78% |
| Q4 2022 | 2022-12-31 | 52.3M | 507,593 | +0.98% |
| Q3 2022 | 2022-09-30 | 52.3M | 605,379 | +1.17% |
| Q2 2022 | 2022-06-30 | 52.0M | 590,213 | +1.15% |
| Q1 2022 | 2022-03-31 | 51.9M | 714,020 | +1.39% |
| Q4 2021 | 2021-12-31 | 51.8M | 713,955 | +1.40% |
| Q3 2021 | 2021-09-30 | 51.7M | 6.9M | +15.50% |
| Q2 2021 | 2021-06-30 | 51.4M | 6.8M | +15.15% |
| Q1 2021 | 2021-03-31 | 51.2M | 6.8M | +15.24% |
| Q4 2020 | 2020-12-31 | 51.1M | 6.7M | +15.08% |
| Q3 2020 | 2020-09-30 | 44.8M | 7.8M | +20.94% |
| Q2 2020 | 2020-06-30 | 44.7M | 7.7M | +20.95% |
| Q1 2020 | 2020-03-31 | 44.5M | 7.5M | +20.44% |
| Q4 2019 | 2019-12-31 | 44.4M | 7.6M | +20.59% |
| Q3 2019 | 2019-09-30 | 37.0M | 29.0M | +361.93% |
| Q2 2019 | 2019-06-30 | 36.9M | 29.0M | +365.34% |
| Q1 2019 | 2019-03-31 | 36.9M | — | — |
| Q4 2018 | 2018-12-31 | 36.8M | — | — |
| Q3 2018 | 2018-09-30 | 8.0M | — | — |
| Q4 2017 | 2017-12-31 | 7.9M | — | — |
Kodiak Sciences shares outstanding trends
Over the last five reported fiscal years, Kodiak Sciences's shares outstanding moved from 51.1M to 61.8M, a change of 10.6M. The latest reported quarter, Q2 2026, shows 62.8M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kodiak Sciences filings at SEC.gov ↗